Pharmaceutical Contract Development & Manufacturing Market Research Report 2022: Industry Expected to Reach $30.36 Billion by 2027 at a CAGR of 8.52% - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Pharmaceutical Contract Development & Manufacturing Market Research Report by Service, End User, State - United States Forecast to 2027 - Cumulative Impact of COVID-19" report has been added to ResearchAndMarkets.com's offering.

The United States Pharmaceutical Contract Development & Manufacturing Market size was estimated at USD 18.58 billion in 2021 and expected to reach USD 20.09 billion in 2022, and is projected to grow at a Compound Annual Growth Rate (CAGR) of 8.52% to reach USD 30.36 billion by 2027.

Market Segmentation & Coverage:

This research report categorizes the Pharmaceutical Contract Development & Manufacturing to forecast the revenues and analyze the trends in each of the following sub-markets:

• Based on Service, the market was studied across Biologics Manufacturing Services, Drug Development Services, Pharmaceutical Manufacturing Services, and Secondary Packaging Services. The Biologics Manufacturing Services is further studied across Biologics API Manufacturing Services and Biologics FDF Manufacturing Services. The Pharmaceutical Manufacturing Services is further studied across Pharmaceutical API Manufacturing and Pharmaceutical FDF Manufacturing. The Pharmaceutical API Manufacturing is further studied across Capsule Manufacturing Services, Oral Liquid Manufacturing Services, Parenteral/Injectable Manufacturing Services, and Tablet Manufacturing Services.
• Based on End User, the market was studied across Big Pharma, Generic Pharmaceutical Companies, and Small & Mid-Size Pharma.
• Based on State, the market was studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas.

Key Topics Covered:

1. Preface

2. Research Methodology

3. Executive Summary

4. Market Overview

5. Market Insights

5.1. Market Dynamics

5.1.1. Drivers

5.1.2. Restraints

5.1.3. Opportunities

5.1.4. Challenges

5.2. Cumulative Impact of COVID-19

6. Pharmaceutical Contract Development & Manufacturing Market, by Service

6.1. Introduction

6.2. Biologics Manufacturing Services

6.2.1. Biologics API Manufacturing Services

6.2.2. Biologics FDF Manufacturing Services

6.3. Drug Development Services

6.4. Pharmaceutical Manufacturing Services

6.4.1. Pharmaceutical API Manufacturing

6.4.1.1. Capsule Manufacturing Services

6.4.1.2. Oral Liquid Manufacturing Services

6.4.1.3. Parenteral/Injectable Manufacturing Services

6.4.1.4. Tablet Manufacturing Services

6.4.2. Pharmaceutical FDF Manufacturing

6.5. Secondary Packaging Services

7. Pharmaceutical Contract Development & Manufacturing Market, by End User

7.1. Introduction

7.2. Big Pharma

7.3. Generic Pharmaceutical Companies

7.4. Small & Mid-Size Pharma

8. California Pharmaceutical Contract Development & Manufacturing Market

9. Florida Pharmaceutical Contract Development & Manufacturing Market

10. Illinois Pharmaceutical Contract Development & Manufacturing Market

11. New York Pharmaceutical Contract Development & Manufacturing Market

12. Ohio Pharmaceutical Contract Development & Manufacturing Market

13. Pennsylvania Pharmaceutical Contract Development & Manufacturing Market

14. Texas Pharmaceutical Contract Development & Manufacturing Market

15. Competitive Landscape

15.1. FPNV Positioning Matrix

15.1.1. Quadrants

15.1.2. Business Strategy

15.1.3. Product Satisfaction

15.2. Market Ranking Analysis

15.3. Market Share Analysis, By Key Player

15.4. Competitive Scenario

15.4.1. Merger & Acquisition

15.4.2. Agreement, Collaboration, & Partnership

15.4.3. New Product Launch & Enhancement

15.4.4. Investment & Funding

15.4.5. Award, Recognition, & Expansion

Companies Mentioned

• AbbVie, Inc.
• Aenova Group GmbH
• Almac Group
• AMRI Global
• C.H. Boehringer Sohn AG & Ko. KG
• Cambrex Corporation
• Catalent, Inc.
• Danaher Corporation
• Delwis Healthcare Pvt Ltd.
• Evonik Industries AG
• Famar Health Care Services
• Fareva
• Jubilant Life Sciences Limited
• Lonza Group AG
• Pfizer Inc.
• Recipharm AB
• Serum Institute of India Ltd.
• Siegfried Holding AG
• Thermo Fisher Scientific Inc.
• Vetter Pharma-Fertigung GmbH & Co. KG

For more information about this report visit https://www.researchandmarkets.com/r/xv2cmp

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900